Novavax said on Tuesday it signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...
Gregory Gregoriadis, who has died aged 91, pioneered the use of particles known as liposomes for drug targeting and laid the ...
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...
Two new analyses, one from France and one from China, suggest that seasonal influenza vaccination provided moderate protection during the early months of the 2025–26 flu season, despite the rapid ...
The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
WASHINGTON -- The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.
The government of Pakistan is moving to strengthen the country’s healthcare system by promoting domestic vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback